Selected article for: "acute lymphoblastic and lymphoblastic leukemia"

Author: Cho, Sung-Yeon; Lee, Hyeon-Jeong; Lee, Dong-Gun
Title: Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea
  • Document date: 2018_2_27
  • ID: t9tysvr8_33
    Snippet: The major symptoms of Pneumocystis jirovecii pneumonia (PCP) are fever, difficulty breathing, and dry cough rather than purulent sputum. Typical radiologic findings are bilateral diffuse infiltrates originating from the periphery of both lungs, but may be normal at the beginning. PCP can present as segmental consolidation in the upper lobe, or subtle ground glass opacities and pneumothorax. It usually occurs within 6 months after transplantation .....
    Document: The major symptoms of Pneumocystis jirovecii pneumonia (PCP) are fever, difficulty breathing, and dry cough rather than purulent sputum. Typical radiologic findings are bilateral diffuse infiltrates originating from the periphery of both lungs, but may be normal at the beginning. PCP can present as segmental consolidation in the upper lobe, or subtle ground glass opacities and pneumothorax. It usually occurs within 6 months after transplantation but also after 6 months of immunosup-pressive therapy for chronic GVHD [3, 4] . The known risk factors for PCP in hematologic patients are acute lymphoblastic leukemia, allogeneic HSCT recipients, alemtuzumab, fludarabine, cyclophosphamide, rituximab, and steroid use (> 20 mg/day prednisone for 4 weeks) [64] .

    Search related documents:
    Co phrase search for related documents
    • acute lymphoblastic leukemia and dry cough: 1
    • acute lymphoblastic leukemia and ground glass: 1
    • acute lymphoblastic leukemia and hematologic patient: 1
    • acute lymphoblastic leukemia and jirovecii pneumonia: 1
    • acute lymphoblastic leukemia and lymphoblastic leukemia: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
    • acute lymphoblastic leukemia and mg day: 1, 2, 3
    • acute lymphoblastic leukemia and risk factor: 1, 2, 3, 4
    • acute lymphoblastic leukemia and sputum purulent: 1
    • allogeneic HSCT recipient and ground glass: 1
    • allogeneic HSCT recipient and ground glass opacity: 1
    • chronic GVHD and HSCT recipient: 1
    • chronic GVHD and jirovecii pneumonia: 1
    • chronic GVHD and lymphoblastic leukemia: 1, 2
    • chronic GVHD and mg day: 1, 2, 3, 4
    • chronic GVHD and PCP jirovecii pneumonia: 1
    • chronic GVHD and Pneumocystis PCP jirovecii pneumonia: 1
    • chronic GVHD and risk factor: 1